Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005667 | transcription regulator complex | 2 | 1 |
GO:0019185 | snRNA-activating protein complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
Related structures:
AlphaFold database: E9B6Z5
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006351 | DNA-templated transcription | 7 | 1 |
GO:0006366 | transcription by RNA polymerase II | 8 | 1 |
GO:0006383 | transcription by RNA polymerase III | 8 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009059 | macromolecule biosynthetic process | 4 | 1 |
GO:0009301 | snRNA transcription | 8 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016073 | snRNA metabolic process | 7 | 1 |
GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
GO:0032774 | RNA biosynthetic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0042795 | snRNA transcription by RNA polymerase II | 9 | 1 |
GO:0042796 | snRNA transcription by RNA polymerase III | 9 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0097659 | nucleic acid-templated transcription | 6 | 1 |
GO:0098781 | ncRNA transcription | 8 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003677 | DNA binding | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0000976 | transcription cis-regulatory region binding | 5 | 1 |
GO:0000987 | cis-regulatory region sequence-specific DNA binding | 6 | 1 |
GO:0000992 | RNA polymerase III cis-regulatory region sequence-specific DNA binding | 7 | 1 |
GO:0001006 | RNA polymerase III type 3 promoter sequence-specific DNA binding | 8 | 1 |
GO:0001016 | RNA polymerase III transcription regulatory region sequence-specific DNA binding | 6 | 1 |
GO:0001067 | transcription regulatory region nucleic acid binding | 4 | 1 |
GO:0003681 | bent DNA binding | 5 | 1 |
GO:0003690 | double-stranded DNA binding | 5 | 1 |
GO:0043565 | sequence-specific DNA binding | 5 | 1 |
GO:1990837 | sequence-specific double-stranded DNA binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 281 | 283 | PF00675 | 0.282 |
CLV_NRD_NRD_1 | 348 | 350 | PF00675 | 0.363 |
CLV_NRD_NRD_1 | 367 | 369 | PF00675 | 0.353 |
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 416 | 418 | PF00675 | 0.537 |
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.502 |
CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 192 | 194 | PF00082 | 0.519 |
CLV_PCSK_KEX2_1 | 281 | 283 | PF00082 | 0.282 |
CLV_PCSK_KEX2_1 | 367 | 369 | PF00082 | 0.353 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.493 |
CLV_PCSK_KEX2_1 | 416 | 418 | PF00082 | 0.537 |
CLV_PCSK_PC1ET2_1 | 129 | 131 | PF00082 | 0.331 |
CLV_PCSK_PC1ET2_1 | 192 | 194 | PF00082 | 0.519 |
CLV_PCSK_PC7_1 | 363 | 369 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 251 | 255 | PF00082 | 0.287 |
CLV_PCSK_SKI1_1 | 358 | 362 | PF00082 | 0.286 |
CLV_PCSK_SKI1_1 | 368 | 372 | PF00082 | 0.298 |
CLV_PCSK_SKI1_1 | 417 | 421 | PF00082 | 0.499 |
DEG_APCC_DBOX_1 | 367 | 375 | PF00400 | 0.429 |
DEG_APCC_KENBOX_2 | 165 | 169 | PF00400 | 0.401 |
DEG_SPOP_SBC_1 | 246 | 250 | PF00917 | 0.345 |
DOC_MAPK_gen_1 | 126 | 136 | PF00069 | 0.453 |
DOC_MAPK_gen_1 | 40 | 47 | PF00069 | 0.531 |
DOC_MAPK_gen_1 | 416 | 427 | PF00069 | 0.511 |
DOC_MAPK_MEF2A_6 | 129 | 138 | PF00069 | 0.405 |
DOC_MAPK_MEF2A_6 | 40 | 47 | PF00069 | 0.579 |
DOC_USP7_MATH_1 | 145 | 149 | PF00917 | 0.594 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.531 |
DOC_USP7_MATH_1 | 304 | 308 | PF00917 | 0.366 |
DOC_USP7_UBL2_3 | 129 | 133 | PF12436 | 0.416 |
DOC_WW_Pin1_4 | 384 | 389 | PF00397 | 0.287 |
DOC_WW_Pin1_4 | 404 | 409 | PF00397 | 0.145 |
DOC_WW_Pin1_4 | 49 | 54 | PF00397 | 0.575 |
LIG_14-3-3_CanoR_1 | 266 | 274 | PF00244 | 0.282 |
LIG_14-3-3_CanoR_1 | 96 | 106 | PF00244 | 0.586 |
LIG_Actin_WH2_2 | 3 | 21 | PF00022 | 0.458 |
LIG_APCC_ABBA_1 | 379 | 384 | PF00400 | 0.416 |
LIG_BRCT_BRCA1_1 | 389 | 393 | PF00533 | 0.416 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.432 |
LIG_FHA_1 | 376 | 382 | PF00498 | 0.370 |
LIG_FHA_2 | 189 | 195 | PF00498 | 0.483 |
LIG_FHA_2 | 240 | 246 | PF00498 | 0.424 |
LIG_FHA_2 | 310 | 316 | PF00498 | 0.226 |
LIG_FHA_2 | 405 | 411 | PF00498 | 0.370 |
LIG_HP1_1 | 230 | 234 | PF01393 | 0.345 |
LIG_LIR_Gen_1 | 221 | 231 | PF02991 | 0.326 |
LIG_LIR_Gen_1 | 272 | 280 | PF02991 | 0.321 |
LIG_LIR_Gen_1 | 290 | 300 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 221 | 226 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 272 | 276 | PF02991 | 0.321 |
LIG_LIR_Nem_3 | 290 | 295 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 310 | 316 | PF02991 | 0.290 |
LIG_LIR_Nem_3 | 333 | 338 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 421 | 425 | PF02991 | 0.490 |
LIG_OCRL_FandH_1 | 253 | 265 | PF00620 | 0.397 |
LIG_Pex14_1 | 81 | 85 | PF04695 | 0.546 |
LIG_SH2_CRK | 394 | 398 | PF00017 | 0.272 |
LIG_SH2_SRC | 382 | 385 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.551 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 335 | 338 | PF00017 | 0.281 |
LIG_SH2_STAT5 | 394 | 397 | PF00017 | 0.273 |
LIG_SH2_STAT5 | 426 | 429 | PF00017 | 0.479 |
LIG_SH3_1 | 382 | 388 | PF00018 | 0.416 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.470 |
LIG_SH3_3 | 38 | 44 | PF00018 | 0.422 |
LIG_SH3_3 | 382 | 388 | PF00018 | 0.283 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.369 |
LIG_SUMO_SIM_par_1 | 134 | 139 | PF11976 | 0.418 |
LIG_SUMO_SIM_par_1 | 230 | 236 | PF11976 | 0.345 |
LIG_SUMO_SIM_par_1 | 377 | 384 | PF11976 | 0.416 |
LIG_SUMO_SIM_par_1 | 43 | 48 | PF11976 | 0.556 |
LIG_TRAF2_1 | 14 | 17 | PF00917 | 0.557 |
LIG_TRAF2_1 | 149 | 152 | PF00917 | 0.534 |
LIG_TRAF2_1 | 407 | 410 | PF00917 | 0.422 |
LIG_WRC_WIRS_1 | 161 | 166 | PF05994 | 0.595 |
LIG_WW_3 | 93 | 97 | PF00397 | 0.588 |
MOD_CK1_1 | 188 | 194 | PF00069 | 0.455 |
MOD_CK1_1 | 387 | 393 | PF00069 | 0.287 |
MOD_CK1_1 | 404 | 410 | PF00069 | 0.287 |
MOD_CK1_1 | 76 | 82 | PF00069 | 0.532 |
MOD_CK2_1 | 145 | 151 | PF00069 | 0.442 |
MOD_CK2_1 | 304 | 310 | PF00069 | 0.386 |
MOD_CK2_1 | 404 | 410 | PF00069 | 0.370 |
MOD_CK2_1 | 76 | 82 | PF00069 | 0.532 |
MOD_CK2_1 | 97 | 103 | PF00069 | 0.458 |
MOD_Cter_Amidation | 127 | 130 | PF01082 | 0.320 |
MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.404 |
MOD_GlcNHglycan | 306 | 309 | PF01048 | 0.416 |
MOD_GlcNHglycan | 344 | 347 | PF01048 | 0.295 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.525 |
MOD_GSK3_1 | 336 | 343 | PF00069 | 0.287 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.569 |
MOD_LATS_1 | 340 | 346 | PF00433 | 0.345 |
MOD_NEK2_1 | 247 | 252 | PF00069 | 0.416 |
MOD_NEK2_1 | 320 | 325 | PF00069 | 0.393 |
MOD_NEK2_1 | 336 | 341 | PF00069 | 0.187 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.535 |
MOD_NEK2_2 | 160 | 165 | PF00069 | 0.594 |
MOD_NEK2_2 | 309 | 314 | PF00069 | 0.378 |
MOD_PIKK_1 | 97 | 103 | PF00454 | 0.507 |
MOD_Plk_1 | 150 | 156 | PF00069 | 0.475 |
MOD_Plk_1 | 309 | 315 | PF00069 | 0.268 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.605 |
MOD_ProDKin_1 | 384 | 390 | PF00069 | 0.287 |
MOD_ProDKin_1 | 404 | 410 | PF00069 | 0.145 |
MOD_ProDKin_1 | 49 | 55 | PF00069 | 0.568 |
MOD_SUMO_for_1 | 118 | 121 | PF00179 | 0.454 |
MOD_SUMO_for_1 | 164 | 167 | PF00179 | 0.523 |
TRG_DiLeu_BaLyEn_6 | 132 | 137 | PF01217 | 0.479 |
TRG_ENDOCYTIC_2 | 199 | 202 | PF00928 | 0.551 |
TRG_ENDOCYTIC_2 | 335 | 338 | PF00928 | 0.299 |
TRG_ENDOCYTIC_2 | 394 | 397 | PF00928 | 0.393 |
TRG_ER_diArg_1 | 280 | 282 | PF00400 | 0.282 |
TRG_ER_diArg_1 | 3 | 5 | PF00400 | 0.487 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JRS6 | Bodo saltans | 30% | 89% |
A0A1X0P603 | Trypanosomatidae | 40% | 94% |
A0A3Q8IJI9 | Leishmania donovani | 94% | 100% |
A0A3R7KX62 | Trypanosoma rangeli | 39% | 97% |
A4HND3 | Leishmania braziliensis | 91% | 100% |
A4IC05 | Leishmania infantum | 94% | 100% |
C9ZYK0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 96% |
E9AFU3 | Leishmania major | 96% | 100% |
Q8IS08 | Leptomonas seymouri | 72% | 90% |
V5BCJ0 | Trypanosoma cruzi | 39% | 97% |